Results 151 to 160 of about 910,008 (206)

NTRK-rearranged spindle cell neoplasm of the female genital tract: case report and literature review

Frontiers in Oncology
NTRK-rearranged spindle cell neoplasm is a rare subtype of soft tissue sarcoma that occasionally arises in the lower female genital tract. Accurate diagnosis is clinically important, as these tumors generally display low-grade malignant behavior and may ...
Lulu Feng, Lulu Feng, Lei Li, Lei Li, Yanmei He, Yanmei He, Wei Jiang, Wei Jiang   +7 more
doaj   +1 more source

Immunohistochemistry and next-generation sequencing for NTRK fusion detection in differentiated thyroid cancer of children, adolescents and young adults

Brazilian Journal of Oncology
Introduction: Pan-TRK immunohistochemistry staining can assess the protein expression from NTRK gene fusions. A little is known about its utility in differentiated thyroid cancer samples from children, adolescents, and young adults patients.
Ana Clara Oliveira Tosta Telles, Gabriel Jeferson Rodríguez Machado, Juliana Lima von-Ammon, Rafael Reis Campos da-Matta, Taíse Lima Cerqueira de-Oliveira, Fabyan Esberard de Lima Beltrão, Alexandre Rolim da-Paz, Fabio Hecht, Guilherme de Castro Lopes, Leonardo Freitas Boaventura Rios, Bruno da Silva Lisboa, Helton Estrela Ramos   +11 more
doaj   +1 more source

1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial

Annals of Oncology, 2023
B. Solomon, A. Drilon, J.J. Lin, L. Bazhenova, K. Goto, J. D. de Langen, D-W. Kim, J. Wolf, C. Springfeld, S. Popat, D. Lim, C. Baik, A. Hervieu, V. Moreno Garcia, N. Yang, S. Thamake, F. Ades, D. Trone, B. Besse   +18 more
semanticscholar   +1 more source

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls

Modern Pathology, 2019
James P. Solomon, I. Linkov, Andréa Rosado, Kerry A Mullaney, Ezra Y. Rosen, D. Frosina, A. Jungbluth, A. Zehir, R. Benayed, A. Drilon, D. Hyman, M. Ladanyi, A. Sireci, J. Hechtman   +13 more
semanticscholar   +1 more source

Challenges in the Diagnosis of NTRK Fusion-Positive Cancers [PDF]

Journal of Thoracic Oncology, 2020
Oliver, Gautschi, Lukas, Bubendorf, Serge, Leyvraz, Roopika, Menon, Joachim, Diebold   +4 more
openaire   +2 more sources

Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions [PDF]

\ua9 2025 The AuthorsBackground: Entrectinib, a central nervous system (CNS)-penetrant TRK/ROS1 inhibitor, has demonstrated clinical activity in children with NTRK1/2/3 or ROS1 fusion-positive extracranial solid and CNS tumours.
Andre N, Armstrong AE, Bagchi A, Basu EM, Campbell-Hewson Q, Cardenas A, Casanova M, Ci B, Desai AV, Devlin CE, Fox E, Gajjar A, Hutchinson KE, Meneses-Lorente G, Robinson GW, Ryklansky C, van Tilburg CM, Wang H, Wu Y, Wulff J   +19 more
core  

Larotrectinib in NTRK Fusion-Positive High-Grade Glioneuronal Tumor: A Case Report. [PDF]

Cureus, 2022
Tadipatri R, Eschbacher J, Fonkem E, Kresl J, Azadi A.   +4 more
europepmc   +1 more source

Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion. [PDF]

Neurooncol Adv, 2022
Kurozumi K, Fujii K, Washio K, Ishida J, Otani Y, Sudo T, Tahara M, Ichimura K, Ennishi D, Date I.   +9 more
europepmc   +1 more source

I.18-1 NTRK Fusion Proteins [PDF]

Journal of Thoracic Oncology, 2019
openaire   +1 more source

71P NTRK gene fusions in bilio-pancreatic cancers [PDF]

Annals of Oncology, 2020
A. Demols, L. Perez-Casanova, L. Rocq, M. Charry, N. De Nève, A. Verrellen, A. Ramadhan, C. Van Campenhout, S. De Clercq, C. Maris, J. Closset, V. Lucidi, I. Salmon, N. D'Haene   +13 more
openaire   +1 more source